Dimeric crystal structure of a Bowman-Birk protease inhibitor from pea seeds

Journal of Molecular Biology

Volumn 285, Issue 3, 1999, Pages 1195-1207

  Li De La Sierra, Inés ^a   Quillien, Laurence ^a   Flecker, Peter ^b   Gueguen, Jacques ^a   Brunie, Simone ^a  

^a CEMAGREF   (France)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Bowman Birk inhibitor; Chymotrypsin inhibitor; Fluorescence spectroscopy; Trypsin inhibitor; X ray crystallography

Indexed keywords

CHYMOTRYPSIN; PROTEIN SUBUNIT; PROTEINASE INHIBITOR; TRYPSIN;

ANISOTROPY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; FLUORESCENCE; HYDROGEN BOND; MOLECULAR MODEL; PEA; PLANT SEED; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; X RAY CRYSTALLOGRAPHY;

BOVINAE; GLYCINE MAX; PISUM SATIVUM; SUIDAE;

EID: 0001483373     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1998.2351     Document Type: Article

References (40)

1. Brooks B. R., Bruccoleri R. E., Olafson B. D., States D. J., Swaminathan S., Karplus M. CHARMm: a programme for macromolecular energy minimization and dynamics calculations. J. Comp. Chem. 4:1983;187-217.
2. Brünger A. T., Kuriyan J., Karplus M. Crystallographic R factor refinement by molecular dynamics. Science. 235:1987;458-460.
3. CCP4. The CCP4 suite: programmes for protein crystallography. Acta Crystallog. sect. D. 50:1994;760-763.
4. Chen P., Rose J., Love R., Wei C. H., Wang B. C. Reactive sites of an anticarcinogenic Bowman-Birk protease inhibitor are similar to other trypsin inhibitors. J. Biol. Chem. 267:1992;1990-1994.
5. de Freitas S. M., de Mello L. V., da Silva M. C. M., Vriend G., Neshich G., Ventura M. Analysis of the black-eyed pea trypsin and chymotrypsin inhibitor-α-chymotrypsin complex. FEBS Letters. 409:1997;121-127.
6. Ferrasson E., Quillien L., Gueguen J. Amino acid sequence of a Bowman-Birk protease inhibitor from pea seeds. J. Protein Chem. 14:1995;467-475.
7. Flecker P. Analysis of structure-activity relationships of the Bowman-Birk inhibitor of serine proteinases. Toward a rational design of new cancer chemopreventive agents. Troll W., Kennedy A. R. Protease Inhibitors as Cancer Chemopreventive Agents. 1993;161-176 Plenum Press, New York.
8. Fruton J. S. The specificity of proteinases toward protein substrates. Reich E., Rifkin D. B., Shaw E. Proteases and Biological Control. 1975;33-50 Cold Spring Harbor Laboratory.
9. Gaier J. R., Tulinsky A., Liener I. E. Formation, crystallization, and preliminary crystallographic data of the ternary complex of alpha-chymotrypsin, beta-trypsin, and the Bowman-Birk inhibitor. J. Biol. Chem. 256:1981;11417-11419.
10. Harms-Ringdahl M., Forsberg J., Fedorcsák I., Ehrenberg L. Trypsin inhibitory activity of a polypeptide isolated from red kidney beans that also enhances lymphocyte stimulation. Biochem. Biophys. Res. Commun. 86:1979;492-499.
11. Harry J. B., Steiner R. F. A soybean proteinase inhibitor. Thermodynamic and kinetic parameters of association with enzymes. Eur. J. Biochem. 16:1970;174-179.
12. Hecht H. J., Szardenings M., Collins J., Schomburg D. Three-dimensional structure of the complexes between bovine chymotrypsinogen A and two recombinant variants of human pancreatic secretory trypsin inhibitor (Kazal-type). J. Mol. Biol. 220:1991;711-722.
13. Hilder V. A., Gatehouse A. M. R., Sheerman S. E., Barker R. F., Boulter D. A novel mechanism of insect resistance engineered into tobacco. Nature. 330:1987;160-163.
14. Ikenaka T., Norioka S. Bowman-Birk family serine proteinase inhibitors. Barrett A. J., Salvesen G. Proteinase Inhibitors. 1986;361-374 Elsevier, Amsterdam.
15. Jancarik J., Kim S. H. Sparse matrix sampling: a screening method for crystallization of proteins. J. Appl. Crystallog. 24:1991;409-411.
16. Kinosita K. Jr, Kawato S., Ikegami A. A theory of fluorescence polarization decay in membranes. Biophys. J. 20:1977;289-305.
17. Kraulis P. J. MOLSCRIPT: a programme to produce both detailed and shematic plots of protein structure. J. Appl. Crystallog. 24:1991;946-950.
18. Laskowski R. A., MacArthur M. W., Moss D. S., Thornton J. M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallog. 26:1993;283-291.
19. Leslie A. G. W. Recent changes to the MOSFLM package for processing film and image plate data. Joint CCP4 and ESF-EACBM Newsletter on Protein Crystallography. 1992;SERC Daresbury Laboratory, Warrington.
20. Li Y., Huang Q., Zhang S., Liu S., Chi C., Tang Y. Studies on an artificial inhibitor peptide derived from the mung bean trypsin inhibitor: chemical synthesis, refolding, and crystallographic analysis of its complex with trypsin. J. Biochem. (Tokyo). 116:1994;18-25.
21. Livesey A. K., Brochon J. C. Analysing the distribution of decay constants in pulse-fluorimetry using the maximum entropy method. Biophys. J. 52:1987;693-506.
22. Luzzati V. Traitement statistique des erreurs dans la détermination des structures cristallines. Acta Crystallog. 5:1952;802-810.
23. Manavalan P., Johnson W. C. Jr. Variable selection method improves the prediction of secondary structure from circular dichroisme spectra. Anal. Biochem. 167:1987;76-85.
24. Marquart M., Walter J., Deisenhofer J., Bode W., Huber R. The geometry of the reactive site and of the peptide groups in trypsin, trypsinogen and its complexes with inhibitors. Acta Crystallog. sect. B. 39:1983;480-490.
25. Matthews B. W. Solvent content of protein crystals. J. Mol. Biol. 33:1968;491-497.
26. Merritt E. A., Murphy M. E. P. Raster3D Version 2.0 - A programme for photorealistic molecular graphics. Acta Crystallog. sect. D. 50:1994;869-873.
27. Navaza J. AMoRe. An automated package for molecular replacement. Acta Crystallog. sect. A. 50:1994;157-163.
28. Nicholls A., Bharadwaj R., Honig B. GRASP: graphical representation and analysis of surface properties. Biophys. J. 64:1993;A166.
29. Odani S., Ikenaka T. Studies on soybean trypsin inhibitors. J. Biochem. (Tokyo). 83:1978;737-745.
30. Otwinowski Z. DENZO. Sawyer L., Isaacs N., Bailey S. Data Collection and Processing. 1993;56-62 SERC Daresbury Laboratory, Warrington.
31. Pouvreau L., Chobert J. M., Briand L., Quillien L., Tran V., Gueguen J., Haertle T. Effect of pea and bovine trypsin inhibitors on wild-type and modified trypsins. FEBS Letters. 423:1998;167-172.
32. Prakash B., Murthy M. R., Sreerama Y. N., Sarma P. R., Rao D. R. Crystallization and preliminary X-ray diffraction studies on a trypsin/chymotrypsin double-headed inhibitor from horse gram. J. Mol. Biol. 235:1994;364-366.
33. Quillien L., Ferrasson E., Molle D., Gueguen J. Trypsin inhibitor polymorphism: multigene family expression and posttranslational modification. J. Protein Chem. 16:1997;195-203.
34. Roussel A., Cambillau C. TURBO-FRODO. 1992;Biographics, LCCMB, Marseille.
35. Schechter I., Berger M. On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27:1967;157-162.
36. Suzuki A., Yamane T., Ashida T., Norioka S., Hara S., Ikenazka T. Crystallographic refinement of Bowman-Birk type protease inhibitor A-II from peanut (Arachi hypogaea) at 2.3 Å Resolution. J. Mol. Biol. 234:1993;722-734.
37. Tsunogae Y., Tanaka I., Yamane T., Kikkawa J., Ashida T., Ishikawa C., Watanabe K., Nakamura S., Takahashi K. Structure of the trypsin-binding domain of Bowman-Birk type protease inhibitor and its interaction with trypsin. J. Biochem. (Tokyo). 100:1986;1637-1646.
38. Vincent M., Li De La Sierra I. M., Berberan-Santos M. N., Diaz A., Diaz M., Padrón G., Gallay J. Time-resolved fluorescence study of human recombinant interferon alpha 2. Association state of the protein, spatial proximity of the two tryptophan residues. Eur. J. Biochem. 210:1992;953-961.
39. Voss R. H., Ermler U., Essen L. O., Wenzl G., Kim Y. M., Flecker P. Crystal structure of the bifunctional soybean Bowman-Birk inhibitor at 0.28-nm resolution. Structural pecularities in a folded protein conformation. Eur. J. Biochem. 242:1996;122-131.
40. Werner M. H., Wemmer D. E. Three-dimensional structure of soybean trypsin/chymotrypsin Bowman-Birk inhibitor in solution. Biochemistry. 31:1992;999-1010.